Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Mozafancogene autotemcel by Rocket Pharmaceuticals for Fanconi Anemia: Likelihood of Approval
Mozafancogene autotemcel is under clinical development by Rocket Pharmaceuticals and currently in Phase II for Fanconi Anemia. According to GlobalData,...